Michael Barbella, Managing Editor05.24.21
The U.S. Patent and Trademark Office has issued Life Spine its 200th patent.
“With our 200th patent granted, Life Spine has one of the highest patent outputs per employee in the industry and this rich IP portfolio is a key driver to our success,” said Michael Butler, Life Spine president and CEO. “Our strong intellectual property position and R&D dedication allows us to serve our customers with the best performing products possible. Our Micro Invasive expandable products are gaining consistent adoption as we position ourselves for some of the largest growth in the industry.”
Life Spine’s IP portfolio consists of over 265 patents and applications with a strong position around expandable technology. With over 11 expandable 510(k) clearances and an additional 17 in the queue, Life Spine has the most advanced expandable product offering to date, according to the company. Migrating procedures into the ASC is one key driver to building out the procedural portfolio, making minimally invasive procedures even smaller, Micro Invasive.
Surgeon interest in the clinical advantages of this enabling technology is high and Life Spine’s product pipeline and clinical research efforts continue to increase to meet the needs of physicians and their patients.
“With our 200th patent granted, Life Spine has one of the highest patent outputs per employee in the industry and this rich IP portfolio is a key driver to our success,” said Michael Butler, Life Spine president and CEO. “Our strong intellectual property position and R&D dedication allows us to serve our customers with the best performing products possible. Our Micro Invasive expandable products are gaining consistent adoption as we position ourselves for some of the largest growth in the industry.”
Life Spine’s IP portfolio consists of over 265 patents and applications with a strong position around expandable technology. With over 11 expandable 510(k) clearances and an additional 17 in the queue, Life Spine has the most advanced expandable product offering to date, according to the company. Migrating procedures into the ASC is one key driver to building out the procedural portfolio, making minimally invasive procedures even smaller, Micro Invasive.
Surgeon interest in the clinical advantages of this enabling technology is high and Life Spine’s product pipeline and clinical research efforts continue to increase to meet the needs of physicians and their patients.